Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR TrialAnatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Early Stage HER2-Positive Breast Carcinoma; Early Stage Triple-Negative Breast CarcinomaRecruitingPhase 22026-09-24NCT07407920

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
M.D. Anderson Cancer Center1145

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
M D Anderson Cancer CenterHoustonUnited States667